|

Brain Connectivity Changes in Glioma Patients During Treatment

RECRUITINGSponsored by Johannes Kepler University of Linz
Actively Recruiting
SponsorJohannes Kepler University of Linz
Started2026-05
Est. completion2029-09
Eligibility
Age18 Years – 64 Years
Healthy vol.Accepted

Summary

The goal of this observational study is to better understand how the brain changes during the treatment of glioma. In particular, the study looks at changes in important brain areas that are responsible for functions such as movement, language, or sensation, as well as the nerve fiber pathways that connect these areas. The main question this study aims to answer is: How do important brain areas and their connections adapt and reorganize over the course of glioma treatment? Patients with glioma will undergo repeated brain imaging examinations as part of their regular medical care. These images will be analyzed over time to observe changes in brain activity and structure during different stages of therapy. By studying these changes, researchers hope to gain new insights into the brain's ability to adapt (neuroplasticity) throughout the entire course of glioma treatment.

Eligibility

Age: 18 Years – 64 YearsHealthy volunteers accepted
Inclusion Criteria:

* Patients with diffuse gliomas (WHO grade 2-4).
* Age \>18 years and \<65 years.
* Written participant information and informed consent provided and signed.
* Signed informed consent for functional magnetic resonance imaging (fMRI).

Exclusion Criteria:

* Age \<18 years or \>65 years.
* Pregnancy.
* Contraindications to MRI, including but not limited to:

  * Active medical implants (e.g., pain pump, defibrillator, cardiac pacemaker),
  * Orthodontic braces,
  * Metallic tattoos,
  * Non-removable piercings,
  * Known metallic foreign bodies,
  * Claustrophobia.
* Cerebral metastases from secondary (non-primary) tumors.
* Absence of baseline BOLD functional MRI and/or baseline neurocognitive assessment.
* Failure to provide written participant information and informed consent.
* Karnofsky Performance Status (KPS) \<60, unless feasibility of clinical-psychological testing and BOLD fMRI is confirmed by the investigator in consultation with clinical psychology, radiology staff, and the patient.

Conditions5

CancerGlioma (Any Grade) in the BrainGliomas, MalignantNeurocognitive FunctionfMRI Research

Browse More Trials

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.